This post was originally published on this site
https://i-invdn-com.investing.com/news/LYNXNPEC0E0NG_M.jpgAkero Therapeutics, Inc. (Nasdaq: NASDAQ:AKRO) 22% HIGHER; will hold an investor conference on Tuesday, October 10 at 8:00 a.m. ET to share topline week 36 results from its SYMMETRY study, a double-blind, placebo-controlled Phase 2b study evaluating the efficacy of efruxifermin (EFX) in patients with compensated cirrhosis due to non-alcoholic steatohepatitis (NASH).
PagerDuty, Inc. (NYSE:PD) 6% LOWER; intends to offer, subject to market conditions and other factors, $350 million principal amount of Convertible Senior Notes due 2028.
Hyatt Hotels Corp . (NYSE:H) 5% HIGHER; will replace National Instruments (NASDAQ:NATI) in the S&P MidCap 400 effective prior to the opening of trading on Thursday, October 12.
Juniper Networks (NYSE:JNPR) 2% LOWER; JPMorgan downgraded from Overweight to Neutral.
Corning (NYSE:GLW) 2% LOWER; JPMorgan downgraded from Overweight to Neutral.